ESR2 and cancer: The actual model supports that ERα has oncogenic functions, as seen in murine models where its activation leads to an increased proliferation of cancer cells24–26; on the other hand, ERβ is thought to act as a tumor suppressor since its loss promotes prostate hyperplasia and the development of the disease21,27–30.